Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Baoquan Pharmaceutical is a pharmaceutical manufacturing enterprise located in Hegang, Heilongjiang Province, China. As a subsidiary of the Beidahuang Group, the company specializes in the production of Traditional Chinese Medicine (TCM) and chemical drug formulations. Its manufacturing facilities are GMP-certified and include production lines for large-volume injections, small-volume injections, tablets, and capsules. The company's product portfolio primarily targets therapeutic areas such as cardiovascular health, respiratory diseases, and anti-inflammatory treatments. Key products include Compound Salvia Miltiorrhiza Injection and various essential chemical generics like Ribavirin and Dexamethasone. Baoquan Pharmaceutical plays a significant role in the regional healthcare industry of Northeast China, leveraging the resources of its parent state-owned enterprise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Baoquan Pharmaceutical.